Additionally, expression levels of apoptosis markers were correspondingly elevated in the HCC‐PDXOs treated with the combination, demonstrating the potential of AZD7762 and OTX‐015 against MYC‐deregulated HCC (Figure 6a). The gene discussed is MYC; the disease is hepatocellular carcinoma.